Abdera Therapeutics

📍 Vancouver, Canada👥 48 employees💰 Last funded Mar 2023
Biotechnology Research🌐 abderatx.com
Website LinkedIn
Abdera Therapeutics Inc. is a precision oncology company developing next-generation targeted radiation therapies - one of the most cutting-edge and highly promising areas of drug development. The company is built on a proprietary modular technology platform optimized for the delivery of radioisotopes to selectively destroy tumor cells while sparing healthy cells. Abdera is using this platform to enable the rapid development of a broad range of safe and efficacious therapies serving cancer patients with limited treatment options. Abdera Therapeutics is growing rapidly and seeking key new team members who thrive at the cutting-edge of innovation. Come join us and be a part of the ground-breaking team set to unlock the power of targeted radiotherapy!
3
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Canada
2
United States
1
Investor activity2021–2023 · investors recorded per year
2021220231
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Abdera Therapeutics?
Abdera Therapeutics has 3 investors on record on gritt.io.
When did Abdera Therapeutics last raise funding?
The most recent investment in Abdera Therapeutics recorded on gritt.io was in March 2023.
What industry is Abdera Therapeutics in?
Abdera Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Abdera Therapeutics based?
Abdera Therapeutics is headquartered in Vancouver, Canada.